NCT06293612View on ClinicalTrials.gov

Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

302

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

November 30, 2022

Conditions
Locally Advanced Rectal CancerDistant Metastasis
Interventions
OTHER

No intervention was administrated to the two cohorts.

Trial Locations (1)

100021

National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

NCT06293612 - Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer | Biotech Hunter | Biotech Hunter